facebook pixel
Our recent U.S. FDA & European Medicines Agency (EMA) submissions reflect our commitment to early intervention for adults with high-risk smoldering #MultipleMyeloma, aiming to intercept the disease earlier: t.co/dLTCsR7Y57 #JNJOncology t.co/fHEudSCErp
https://twitter.com/JNJInnovMed/status/1854881390350782903
Posted on Twitter/X ·

 2

 1

 455

Credits
Suggested Credits

Credits on Gondola describe each credited role and may be incomplete. A brand or featured person is not necessarily the creator.

Tags, Events, and Projects